HidraWear’s Clinical Study won the Gold Award for Best Clinical Research at the 2023 Journal of Wound Care Awards.
HidraWear Clinical Study
HidraWear is a major advancement in hard-to-dress wound management
In our Clinical Trial, HidraWear delivered meaningful patient improvements across the spectrum of patient pain points
CE GAX 001
Results based on a 21 day clinical study
Detailed Metric Results
Traditional Wound
Dressings(Day 0)
$ 99
Per MonthQuality of Life (DLQI)19.4
Difficulty Dressing Wounds
6.5
Time Consumption
6.9
Dressing Comfort
8.1
Dressing Related Pain
5.5
Retention and Leak Confidence
8.4
Body Confidence
8.5
Using
HidraWear(after 21 days of use)
$ 99
Per MonthQuality of Life (DLQI)4.6
Difficulty Dressing Wounds
0.6
Time Consumption
0.7
Dressing Comfort
1
Dressing Related Pain
0.8
Retention and Leak Confidence
1.2
Body Confidence
3.8
Note: The Quality of Life score was measured using the DLQI questionnaire, day 0 vs day 21. All other questions were rated on an 11-point VAS, where zero was the best possible score and 10 was the worst possible score.
DLQI scoring system
0-1 = no effect at all on patient’s life
2-5 = small effect on patient’s life
6-10 = moderate effect on patient’s life
11-20 = Very large effect on patient’s life
21-30 = Extremely large effect on patient’s life
Of the participants who required pain relief in advance of a dressing change at baseline (n=5), none required pain relief in advance of a dressing change by day 21 of the trial using HidraWear.
Request more information
"*" indicates required fields
